Comparison

Oncology

Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.

The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.

To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.

 

Click on the organs and learn more about cancer types

´

General information

Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.

Relevant products for oncology research

2719 Item(s)

per page

Name PDF Type Clone Specific against Appl. Host Item no. Amount Price
Lilotomab Biosimilar -­ Research Grade Hu FA CHO cells ICH5645-1mg

IchorBio
1 mg Login
Compare
Mitazalimab Biosimilar -­ Research Grade Hu FA CHO cells ICH5689-25mg

IchorBio
25 mg Login
Compare
Mitazalimab Biosimilar -­ Research Grade Hu FA CHO cells ICH5689-50mg

IchorBio
50 mg Login
Compare
Mitazalimab Biosimilar -­ Research Grade Hu FA CHO cells ICH5689-5mg

IchorBio
5 mg Login
Compare
Modotuximab Biosimilar -­ Research Grade Hu FA CHO cells ICH5691-10mg

IchorBio
10 mg (2 x 5 mg) Login
Compare
Modotuximab Biosimilar -­ Research Grade Hu FA CHO cells ICH5691-1mg

IchorBio
1 mg Login
Compare
Modotuximab Biosimilar -­ Research Grade Hu FA CHO cells ICH5691-25mg

IchorBio
25 mg Login
Compare
Modotuximab Biosimilar -­ Research Grade Hu FA CHO cells ICH5691-50mg

IchorBio
50 mg Login
Compare
Modotuximab Biosimilar -­ Research Grade Hu FA CHO cells ICH5691-5mg

IchorBio
5 mg Login
Compare
Mozistobart Biosimilar -­ Research Grade Hu FA CHO cells ICH5693-10mg

IchorBio
10 mg (2 x 5 mg) Login
Compare
Mozistobart Biosimilar -­ Research Grade Hu FA CHO cells ICH5693-1mg

IchorBio
1 mg Login
Compare
Mozistobart Biosimilar -­ Research Grade Hu FA CHO cells ICH5693-25mg

IchorBio
25 mg Login
Compare
Mozistobart Biosimilar -­ Research Grade Hu FA CHO cells ICH5693-50mg

IchorBio
50 mg Login
Compare
Mozistobart Biosimilar -­ Research Grade Hu FA CHO cells ICH5693-5mg

IchorBio
5 mg Login
Compare
Naratuximab Biosimilar -­ Research Grade Hu FA CHO cells ICH5698-10mg

IchorBio
10 mg (2 x 5 mg) Login
Compare
Naratuximab Biosimilar -­ Research Grade Hu FA CHO cells ICH5698-1mg

IchorBio
1 mg Login
Compare
Naratuximab Biosimilar -­ Research Grade Hu FA CHO cells ICH5698-25mg

IchorBio
25 mg Login
Compare
Naratuximab Biosimilar -­ Research Grade Hu FA CHO cells ICH5698-50mg

IchorBio
50 mg Login
Compare
Naratuximab Biosimilar -­ Research Grade Hu FA CHO cells ICH5698-5mg

IchorBio
5 mg Login
Compare
Narnatumab Biosimilar -­ Research Grade Hu FA CHO cells ICH5699-10mg

IchorBio
10 mg (2 x 5 mg) Login
Compare
Narnatumab Biosimilar -­ Research Grade Hu FA CHO cells ICH5699-1mg

IchorBio
1 mg Login
Compare
Narnatumab Biosimilar -­ Research Grade Hu FA CHO cells ICH5699-25mg

IchorBio
25 mg Login
Compare
Narnatumab Biosimilar -­ Research Grade Hu FA CHO cells ICH5699-50mg

IchorBio
50 mg Login
Compare
Narnatumab Biosimilar -­ Research Grade Hu FA CHO cells ICH5699-5mg

IchorBio
5 mg Login
Compare
Nerelimomab Biosimilar -­ Research Grade Hu FA CHO cells ICH5708-10mg

IchorBio
10 mg (2 x 5 mg) Login
Compare
Name Price
Lilotomab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 1 mg
Available
Mitazalimab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 25 mg
Available
Mitazalimab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 50 mg
Available
Mitazalimab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 5 mg
Available
Modotuximab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 10 mg (2 x 5 mg)
Available
Modotuximab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 1 mg
Available
Modotuximab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 25 mg
Available
Modotuximab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 50 mg
Available
Modotuximab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 5 mg
Available
Mozistobart Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 10 mg (2 x 5 mg)
Available
Mozistobart Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 1 mg
Available
Mozistobart Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 25 mg
Available
Mozistobart Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 50 mg
Available
Mozistobart Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 5 mg
Available
Naratuximab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 10 mg (2 x 5 mg)
Available
Naratuximab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 1 mg
Available
Naratuximab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 25 mg
Available
Naratuximab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 50 mg
Available
Naratuximab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 5 mg
Available
Narnatumab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 10 mg (2 x 5 mg)
Available
Narnatumab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 1 mg
Available
Narnatumab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 25 mg
Available
Narnatumab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 50 mg
Available
Narnatumab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 5 mg
Available
Nerelimomab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 10 mg (2 x 5 mg)
Available

2719 Item(s)

per page